Skip to main content
Veterinary Medicines

KESIUM 500 MG / 125 MG CHEWABLE TABLETS FOR DOGS

Authorised
  • Amoxicillin trihydrate
  • Potassium clavulanate

Product identification

Medicine name:
KESIUM 500 MG / 125 MG CHEWABLE TABLETS FOR DOGS
KESIUM
Active substance:
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    574.00
    milligram(s)
    /
    1.00
    Tablet
  • Potassium clavulanate
    149.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Box of 80 blisters of 6 chewable breakable tablets
  • Box of 80 blisters of 6 chewable breakable tablets
  • Box of 80 blisters of 6 chewable breakable tablets
  • Box of 80 blisters of 6 chewable breakable tablets
  • Box of 80 blisters of 6 chewable breakable tablets
  • Box of 80 blisters of 6 chewable breakable tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Salute Animale S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104319
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0225/005
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 9/01/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."